Advertisement

ADVERTISEMENT

value-based care

Blog
Can Proactive Value-Based Care And ACOs Have An Impact On Amputation Prevention?
01/28/2021
Mark Hinkes DPM FACFAS FAPWCA DABFAS
In many countries, there is a single payer system, in which the government pays the cost of health care and the providers are on salary. In this model, there is no billing as providers merely provide the services mandated by the government...
In many countries, there is a single payer system, in which the government pays the cost of health care and the providers are on salary. In this model, there is no billing as providers merely provide the services mandated by the government...
In many countries, there is a...
01/28/2021
Podiatry Today
Perspectives
Approaching Clinical Pathway Development as an Art
11/18/2020
Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD
Craig Ornstein, PhD
Seth Gordon, MBA
Abstract: In health care, rules and regulations are in place for good reason, but there is an art to integrating them into care effectively to benefit patients as well as the other stakeholders­—clinically and...
Abstract: In health care, rules and regulations are in place for good reason, but there is an art to integrating them into care effectively to benefit patients as well as the other stakeholders­—clinically and...
...
11/18/2020
Journal of Clinical Pathways
News
Researchers Identify Predictors of Longer Hospital Stay for Patients Undergoing Allogeneic Transplant
08/18/2020
Among patients who undergo allogeneic hematopoietic stem cell transplant (allo-HSCT), hospital length of stay is a driver for increased cost and can be predicted using patient- and transplant-related characteristics,...
Among patients who undergo allogeneic hematopoietic stem cell transplant (allo-HSCT), hospital length of stay is a driver for increased cost and can be predicted using patient- and transplant-related characteristics,...
Among...
08/18/2020
Journal of Clinical Pathways
News
First-Year OCM Participation Associated With Fewer Visits, Lower Costs
08/13/2020
In the first year, cancer centers that implement payment models with shared-savings components can be associated with fewer visits and lower costs, however these savings are largely offset by the cost of program...
In the first year, cancer centers that implement payment models with shared-savings components can be associated with fewer visits and lower costs, however these savings are largely offset by the cost of program...
In the...
08/13/2020
Journal of Clinical Pathways
News
Frontline Immune Checkpoint Inhibitors Cost-Effective for Advanced Melanoma
08/07/2020
Nivolumab plus ipilimumab and pembrolizumab are the most cost-effective front-line treatment options for patients with newly diagnosed advanced melanoma and unknown BRAF status, according to a study published in JAMA...
Nivolumab plus ipilimumab and pembrolizumab are the most cost-effective front-line treatment options for patients with newly diagnosed advanced melanoma and unknown BRAF status, according to a study published in JAMA...
...
08/07/2020
Journal of Clinical Pathways
MD Anderson, Philips Collaborate to Offer Personalized Care on a Global Scale
Interview
MD Anderson, Philips Collaborate to Offer Personalized Care on a Global Scale
07/14/2020
In June 2020, The University of Texas MD Anderson Cancer Center and Royal Philips announced a collaboration to provide oncologists with biomarker-driven, evidence-based therapy and clinical trial guidance through...
In June 2020, The University of Texas MD Anderson Cancer Center and Royal Philips announced a collaboration to provide oncologists with biomarker-driven, evidence-based therapy and clinical trial guidance through...
In...
07/14/2020
Journal of Clinical Pathways
Elsevier’s ClinicalPath: Supporting Value-Based Care and the Path Forward
Interview
Elsevier’s ClinicalPath: Supporting Value-Based Care and the Path Forward
07/07/2020
In January 2018, Elsevier—an information analytics business specializing in science and health—acquired Via Oncology – a leading decision-support and clinical pathways vendor. Since that time, Elsevier has rebranded...
In January 2018, Elsevier—an information analytics business specializing in science and health—acquired Via Oncology – a leading decision-support and clinical pathways vendor. Since that time, Elsevier has rebranded...
In...
07/07/2020
Journal of Clinical Pathways
News
CancerLinQ Certification Pathway Offers Automated Quality Reporting
06/25/2020
In June 2020, the American Society of Clinical Oncology (ASCO) launched the SmartLinQ Quality Oncology Practice Initiative (QOPI) Certification Pathway for practices participating in the QOPI Certification...
In June 2020, the American Society of Clinical Oncology (ASCO) launched the SmartLinQ Quality Oncology Practice Initiative (QOPI) Certification Pathway for practices participating in the QOPI Certification...
In...
06/25/2020
Journal of Clinical Pathways
Beyond Face Value: Why Indirect Benefits of Cancer Care Matter
Quality Outlook
Beyond Face Value: Why Indirect Benefits of Cancer Care Matter
05/27/2020
Tom Valuck, MD, JD, and colleagues shed light on the value of indirect benefits of effective cancer care and challenges of measuring such benefits, including insufficient data and patient-focused measures.
Tom Valuck, MD, JD, and colleagues shed light on the value of indirect benefits of effective cancer care and challenges of measuring such benefits, including insufficient data and patient-focused measures.
Tom Valuck, MD, JD, and...
05/27/2020
Journal of Clinical Pathways
Are Value-Based Agreements the Solution to High Drug Prices?
Healthcare Economist
Are Value-Based Agreements the Solution to High Drug Prices?
05/26/2020
Jason Shafrin, PhD, provides commentary on why value-based agreements will likely never make up the majority of drug reimbursement.
Jason Shafrin, PhD, provides commentary on why value-based agreements will likely never make up the majority of drug reimbursement.
Jason Shafrin, PhD, provides...
05/26/2020
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

September 21 ⁠–⁠ September 22
AMP Europe
September 30 ⁠–⁠ October 2
October 1 ⁠–⁠ October 2
SAWC Fall
October 2 ⁠–⁠ October 5
October 5 ⁠–⁠ October 6
SMASH
October 14 ⁠–⁠ October 16
Lymphoma, Leukemia, and Myeloma
October 16 ⁠–⁠ October 19
October 19 ⁠–⁠ October 20
October 26 ⁠–⁠ October 27
October 29 ⁠–⁠ November 2
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use